Ospedale Alessandro Manzoni
About Ospedale Alessandro Manzoni
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute, Naples
5
Hoffmann-La Roche
3
Pfizer
3
University of Milano Bicocca
3
Boston Scientific Corporation
2
Daiichi Sankyo, Inc.
2
ETOP IBCSG Partners Foundation
2
NovoCure Ltd.
2
Abbott Medical Devices
1
Biosense Webster, Inc.
1
Calliditas Therapeutics AB
1
Clinical Trials at Ospedale Alessandro Manzoni
During the past decade, Ospedale Alessandro Manzoni conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 12 clinical trials were completed, i.e. on
average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed
1994-01-01
Unknown status
750
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
2000-11-01
2016-08-01
Completed
1,086
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
2001-11-01
2015-06-01
Completed
5,099
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2001-09-01
Unknown status
700
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
2003-05-01
Completed
385
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases
2001-12-01
2017-03-31
Completed
931
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
2004-04-01
2007-05-01
Completed
5,745
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ospedale Alessandro Manzoni" #1 sponsor was "National Cancer Institute, Naples" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "University of Milano Bicocca" with 3 trials sponsored and "Boston Scientific Corporation"
with 3 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Alessandro Manzoni"
#1 collaborator was "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator, "Mario Negri Institute for Pharmacological Research" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Ospedale Alessandro Manzoni
According to Clinical.Site data, the most researched conditions in "Ospedale Alessandro Manzoni" are
"Breast Cancer" (7 trials), "Ovarian Cancer" (4 trials), "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials) and "Tachycardia" (2 trials). Many other conditions were trialed in "Ospedale Alessandro Manzoni" in a lesser frequency.
Clinical Trials Intervention Types at Ospedale Alessandro Manzoni
Most popular intervention types in "Ospedale Alessandro Manzoni" are "Drug" (25 trials), "Device" (7 trials), "Procedure" (6 trials) and "Other" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials) and "NovoTTF-100A device" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Ospedale Alessandro Manzoni
The vast majority of trials in "Ospedale Alessandro Manzoni" are
26 trials for "All" genders and 12 trials for "Female" genders.
Clinical Trials Status at Ospedale Alessandro Manzoni
Currently, there are NaN active trials in "Ospedale Alessandro Manzoni".
undefined are not yet recruiting,
2 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 20 completed trials in Ospedale Alessandro Manzoni,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Ospedale Alessandro Manzoni, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 5 trials that are defined as “Not Applicable".